X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-04 | EDIT | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S - Sale | $3.42 | -518 | 133,895 | 0% | -$1,774 | ||||||
2024-09-04 | EDIT | O'Neill Gilmore Neil | CEO | S - Sale | $3.42 | -1,555 | 313,724 | 0% | -$5,325 | ||||||
2024-07-25 | EDIT | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S - Sale | $5.42 | -11,886 | 73,136 | -14% | -$64,370 | ||||||
2024-07-19 | EDIT | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S - Sale | $5.21 | -6,619 | 134,413 | -5% | -$34,456 | ||||||
2024-06-04 | EDIT | O'Neill Gilmore Neil | CEO | S - Sale | $5.50 | -12,191 | 315,279 | -4% | -$66,997 | ||||||
2024-06-04 | EDIT | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S - Sale | $5.50 | -511 | 141,032 | 0% | -$2,808 | ||||||
2024-05-20 | EDIT | Lucera Erick | EVP, CFO | S - Sale | $5.61 | -22,337 | 116,829 | -16% | -$125,404 | ||||||
2024-05-13 | EDIT | Hopfield Jessica | Dir | P - Purchase | $5.64 | +45,000 | 67,700 | +198% | +$253,868 | ||||||
| D | 2024-03-05 | EDIT | O'Neill Gilmore Neil | CEO | S - Sale+OE | $9.42 | -77,824 | 327,470 | -19% | -$732,884 | |||||
| D | 2024-03-04 | EDIT | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S - Sale+OE | $9.42 | -20,327 | 141,543 | -13% | -$191,425 | |||||
2023-12-05 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $10.90 | -103 | 74,791 | 0% | -$1,122 | ||||||
2023-11-14 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $8.21 | -695 | 74,894 | -1% | -$5,706 | ||||||
2023-11-07 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $8.40 | -139 | 75,589 | 0% | -$1,168 | ||||||
2023-09-06 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $8.82 | -103 | 75,728 | 0% | -$908 | ||||||
2023-08-11 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $8.59 | -702 | 75,831 | -1% | -$6,033 | ||||||
2023-08-08 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $8.39 | -141 | 76,533 | 0% | -$1,183 | ||||||
2023-07-19 | EDIT | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | S - Sale | $8.80 | -4,317 | 72,055 | -6% | -$37,990 | ||||||
2023-06-05 | EDIT | O'Neill Gilmore Neil | CEO | S - Sale | $9.50 | -6,486 | 130,169 | -5% | -$61,638 | ||||||
2023-06-05 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $9.50 | -105 | 76,674 | 0% | -$998 | ||||||
2023-05-11 | EDIT | Robertson Michelle | EVP, CFO | S - Sale | $9.87 | -949 | 106,610 | -1% | -$9,369 | ||||||
2023-05-11 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $9.87 | -668 | 76,779 | -1% | -$6,594 | ||||||
2023-05-09 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $9.51 | -135 | 77,447 | 0% | -$1,284 | ||||||
| D | 2023-03-03 | EDIT | Robertson Michelle | EVP, CFO | S - Sale+OE | $8.89 | -184 | 107,559 | 0% | -$1,636 | |||||
| D | 2023-03-03 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale+OE | $8.89 | -101 | 77,582 | 0% | -$898 | |||||
2023-02-13 | EDIT | Shearman Mark S | EVP, Chief Scientific Officer | S - Sale | $9.67 | -2,790 | 65,559 | -4% | -$26,966 | ||||||
2023-02-13 | EDIT | Robertson Michelle | EVP, CFO | S - Sale | $9.67 | -4,287 | 76,243 | -5% | -$41,435 | ||||||
2023-02-13 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $9.67 | -3,307 | 60,983 | -5% | -$31,963 | ||||||
2023-02-07 | EDIT | Eaton Bruce | EVP, CBO, CTO | S - Sale | $11.10 | -346 | 64,290 | -1% | -$3,841 | ||||||
2023-01-10 | EDIT | Robertson Michelle | EVP, CFO | S - Sale | $8.16 | -1,752 | 80,530 | -2% | -$14,296 | ||||||
2022-12-05 | EDIT | Robertson Michelle | EVP, CFO | S - Sale | $10.23 | -193 | 82,282 | 0% | -$1,974 | ||||||
2022-12-05 | EDIT | Eaton Bruce | EVP, Chief Business Officer | S - Sale | $10.23 | -102 | 64,636 | 0% | -$1,043 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |